Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication

被引：66

作者：

van Bömmel, F

Wünsche, T

Schürmann, D

Berg, T

机构：

[1] Humboldt Univ, Klinikum Humboldt, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany

[2] Humboldt Univ, Klinikum Humboldt, Med Klin Schwerpunkt Infektiol Charite, Berlin, Germany

来源：

HEPATOLOGY | 2002年 / 36卷 / 02期

关键词：

D O I：

10.1053/jhep.2002.35328

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：507 / 508

页数：2

共 8 条

[1] Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults [J].

Barditch-Crovo, P ;

Deeks, SG ;

Collier, A ;

Safrin, S ;

Coakley, DF ;

Miller, M ;

Kearney, BP ;

Coleman, RL ;

Lamy, PD ;

Kahn, JO ;

McGowan, I ;

Lietman, PS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2733-2739

[2] Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors [J].

Cihlar, T ;

Birkus, G ;

Greenwalt, DE ;

Hitchcock, MJM .

ANTIVIRAL RESEARCH, 2002, 54 (01) :37-45

[3]

JAMES JS, 2001, AIDS TREAT NEWS, V26, P2

[4] Management of hepatitis B: 2000 - Summary of a workshop [J].

Lok, AS ;

Heathcote, EJ ;

Hoofnagle, JH .

GASTROENTEROLOGY, 2001, 120 (07) :1828-1853

[5] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants [J].

Perrillo, R ;

Schiff, E ;

Yoshida, E ;

Statler, A ;

Hirsch, K ;

Wright, T ;

Gutfreund, K ;

Lamy, P ;

Murray, A .

HEPATOLOGY, 2000, 32 (01) :129-134

[6]

Schwetz BA, 2001, JAMA-J AM MED ASSOC, V286, P2660, DOI 10.1001/jama.286.21.2660

[7] Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region [J].

Stuyver, LJ ;

Locarnini, SA ;

Lok, A ;

Richman, DD ;

Carman, WF ;

Dienstag, JL ;

Schinazi, RF .

HEPATOLOGY, 2001, 33 (03) :751-757

[8]

Ying C, 2000, J VIRAL HEPATITIS, V7, P161

← 1 →